Literature DB >> 4332354

The nature of the immune state produced by inactivated vaccinia virus in rabbits.

E A Boulter, H T Zwartouw, D H Titmuss, H B Maber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4332354     DOI： 10.1093/oxfordjournals.aje.a121360

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  26 in total

1.  Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.

Authors:  W H Zhang; D Wilcock; G L Smith
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.

Authors:  R Blasco; B Moss
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  The immune response to infection with vaccinia virus in mice. I. Infection and the production of antibody neutralizing cell-associated and cell-free virus.

Authors:  L M Hutt
Journal:  J Hyg (Lond)       Date:  1975-06

4.  Immune response in rabbits to surface components of extracellular and intracellular forms of vaccinia virus.

Authors:  N Balachandran; P Seth; L N Mohapatra
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

5.  Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination.

Authors:  L B Epstein; D A Stevens; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

6.  Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.

Authors:  Linda S Wyatt; Patricia L Earl; Leigh Anne Eller; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-11       Impact factor: 11.205

Review 7.  Smallpox vaccines for biodefense.

Authors:  Richard B Kennedy; Inna Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

8.  Vaccinia virus entry/fusion complex subunit A28 is a target of neutralizing and protective antibodies.

Authors:  Gretchen E Nelson; Jerry R Sisler; Dev Chandran; Bernard Moss
Journal:  Virology       Date:  2008-09-11       Impact factor: 3.616

9.  Adsorption and penetration of enveloped and naked vaccinia virus particles.

Authors:  L G Payne; E Norrby
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

10.  Camelpox, an emerging orthopox viral disease.

Authors:  Vinayagamurthy Balamurugan; Gnanavel Venkatesan; Veerakyathappa Bhanuprakash; Raj Kumar Singh
Journal:  Indian J Virol       Date:  2013-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.